Endometrial mixed adenocarcinoma
MONDO:0004321An adenocarcinoma that arises from the endometrium and is characterized by the presence of both type I and type II endometrial adenocarcinoma components. The minor component constitutes at least 5% of the entire tumor.
Also known as: endometrial mixed adenocarcinoma
2866 clinical trials for this condition and its sub-types, 10 tagged with Endometrial mixed adenocarcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Hormone blockers join forces against Treatment-Resistant endometrial cancer
Disease control CompletedThis phase II trial tests whether combining two hormone-blocking drugs — onapristone and anastrozole — can shrink tumors or slow cancer growth in women with hormone-receptor-positive endometrial cancer that has not responded to prior chemotherapy. Onapristone blocks progesterone …
Phase 2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could a cancer drug shrink endometrial tumors?
Disease control CompletedThis phase 2 trial tested the drug cabozantinib in 102 women with endometrial cancer that had returned or spread. The drug works by blocking enzymes that help tumors grow and by cutting off their blood supply. Researchers measured how many patients saw their tumors shrink or stop…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC